Speed to therapy Potential to introduce the Reveal system to hospitals and clinics treating bloodstream infections where time-to-effective-therapy is critical, leveraging the under-one-day antibiotic determination to reduce mortality costs and length of stay.

Cost and workflow Opportunity to position SMS array based diagnostics as a low-cost, labor-saving alternative that improves lab throughput, enabling pharmacies and hospital labs to deploy with minimal process disruption and training.

Strategic partnerships Leverage bioMérieux ecosystem and distribution channels to accelerate market access, while exploring co-development or licensing of SMS array technology for broader infectious disease panels and rapid susceptibility testing.

Clinical evidence Highlight the growing body of peer-reviewed publications and independent validations to support adoption, targeting procurement teams and clinical champions with data on reduced time to effective therapy and improved patient outcomes.

Expansion opportunities Tap into large hospital networks and regional health systems, especially where sepsis and antibiotic resistance are high, to scale deployment of Reveal solutions and secure multi-site agreements for standardized workflows.